The World Health Organization has prequalified a tool for the quick diagnosis of hepatitis C. Since treatment for hepatitis C has become affordable and available in low and middle-income countries, the organization believes that the prequalification of an effective diagnostic tool will improve the number of patients cured.
hepatitis C
Breaking News
New hepatitis C drugs that shorten treatment times are largely cost-effective despite their hefty U.S. price tags, according to two new analyses.
France will tax drugmakers whose costly hepatitis C drugs threaten to throw off course its healthcare budget, the government has said, heaping pressure on pharmaceutical companies like Gilead Sciences to cut their prices.
